296 related articles for article (PubMed ID: 17332334)
21. Src regulates the activity of the ING1 tumor suppressor.
Yu L; Thakur S; Leong-Quong RY; Suzuki K; Pang A; Bjorge JD; Riabowol K; Fujita DJ
PLoS One; 2013; 8(4):e60943. PubMed ID: 23585863
[TBL] [Abstract][Full Text] [Related]
22. Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.
Ceruti JM; Ogara MF; Menéndez C; Palmero I; Cánepa ET
Mol Cell Biochem; 2013 Jun; 378(1-2):117-26. PubMed ID: 23459830
[TBL] [Abstract][Full Text] [Related]
23. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor ING1 contributes to epigenetic control of cellular senescence.
Abad M; Moreno A; Palacios A; Narita M; Blanco F; Moreno-Bueno G; Narita M; Palmero I
Aging Cell; 2011 Feb; 10(1):158-71. PubMed ID: 21078114
[TBL] [Abstract][Full Text] [Related]
25. Function of the ING family of PHD proteins in cancer.
Gong W; Suzuki K; Russell M; Riabowol K
Int J Biochem Cell Biol; 2005 May; 37(5):1054-65. PubMed ID: 15743678
[TBL] [Abstract][Full Text] [Related]
26. The new tumor suppressor genes ING: genomic structure and status in cancer.
Ythier D; Larrieu D; Brambilla C; Brambilla E; Pedeux R
Int J Cancer; 2008 Oct; 123(7):1483-90. PubMed ID: 18636562
[TBL] [Abstract][Full Text] [Related]
27. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
28. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
[TBL] [Abstract][Full Text] [Related]
29. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
Cheung KJ; Mitchell D; Lin P; Li G
Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
[TBL] [Abstract][Full Text] [Related]
30. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
31. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
32. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
[TBL] [Abstract][Full Text] [Related]
33. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function.
Zeremski M; Hill JE; Kwek SS; Grigorian IA; Gurova KV; Garkavtsev IV; Diatchenko L; Koonin EV; Gudkov AV
J Biol Chem; 1999 Nov; 274(45):32172-81. PubMed ID: 10542254
[TBL] [Abstract][Full Text] [Related]
34. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
35. Domain recognition of the ING1 tumor suppressor by a panel of monoclonal antibodies.
Suzuki K; Boland D; Gong W; Riabowol K
Hybridoma (Larchmt); 2011 Jun; 30(3):239-45. PubMed ID: 21707358
[TBL] [Abstract][Full Text] [Related]
36. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
37. p33(ING1) enhances UVB-induced apoptosis in melanoma cells.
Cheung KJ; Li G
Exp Cell Res; 2002 Oct; 279(2):291-8. PubMed ID: 12243754
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
Li J; Sejas DP; Burma S; Chen DJ; Pang Q
Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
[TBL] [Abstract][Full Text] [Related]
39. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
[TBL] [Abstract][Full Text] [Related]
40. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
